HomeNAUT • NASDAQ
add
Nautilus Biotechnology Inc
Previous close
$1.30
Day range
$1.24 - $1.36
Year range
$1.11 - $3.09
Market cap
155.70M USD
Avg Volume
111.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.98M | -0.10% |
Net income | -17.59M | -3.35% |
Net profit margin | — | — |
Earnings per share | -0.14 | 0.00% |
EBITDA | -19.55M | -0.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 129.89M | -25.10% |
Total assets | 242.74M | -20.56% |
Total liabilities | 34.01M | -15.42% |
Total equity | 208.73M | — |
Shares outstanding | 126.15M | — |
Price to book | 0.78 | — |
Return on assets | -19.88% | — |
Return on capital | -20.21% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -17.59M | -3.35% |
Cash from operations | -14.31M | -2.94% |
Cash from investing | 37.11M | 190.37% |
Cash from financing | 440.00K | 73.91% |
Net change in cash | 23.24M | 142.48% |
Free cash flow | -9.33M | -16.42% |
About
Founded
2016
Headquarters
Website
Employees
155
